John Boyer Inc’s Novartis NVS Stock Holding History

John Boyer Inc’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.99K	Buy	+21	New	+$3.18K	﹤0.01%	197

Other funds holding NVS

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $273B AUM 15.34% 1-Year Est. Return

Cullen Capital Management New York $9.8B AUM 21.02% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

John Boyer Inc's NVS Position: Q3 2026 in Review

John Boyer Inc opened a new position in Novartis (NVS) in Q3 2026: 21 shares worth $2.99K. The stake represents ﹤0.01% of the portfolio and ranks #197 among its holdings.

1,261 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

John Boyer Inc held 21 shares of Novartis worth $2.99K as of Q3 2026.
Novartis was a new John Boyer Inc position in Q3 2026.
Novartis made up ﹤0.01% of John Boyer Inc's portfolio in Q3 2026, its #197 holding.
1,261 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on John Boyer Inc's 13F filing for Q3 2026, filed 27 Oct 2026.